{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:07Z","timestamp":1793382907026,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1124\/jpet.120.000124","type":"journal-article","created":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T12:55:11Z","timestamp":1601124911000},"page":"469-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats"],"prefix":"10.1016","volume":"375","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-6776","authenticated-orcid":false,"given":"Carly","family":"Baehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April Huseby","family":"Kelcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Khaimraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana E.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata G.","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"AuCoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadyah","family":"Averick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-0184","authenticated-orcid":false,"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000124_bib1","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1021\/acs.molpharmaceut.8b00592","article-title":"Preclinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins","volume":"15","author":"Baruffaldi","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.120.000124_bib2","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3389\/fimmu.2019.01694","article-title":"Techniques to study antigen-specific B cell responses","volume":"10","author":"Boonyaratanakornkit","year":"2019","journal-title":"Front Immunol"},{"key":"10.1124\/jpet.120.000124_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate vaccine immunotherapy for substance use disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.120.000124_bib4","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.120.000124_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biotechadv.2017.03.011","article-title":"Very-large-scale production of antibodies in plants: the biologization of manufacturing","volume":"35","author":"Buyel","year":"2017","journal-title":"Biotechnol Adv"},{"key":"10.1124\/jpet.120.000124_bib6","unstructured":"Centers for Disease Control and Prevention (May 5, 2020) Opioid overdose. https:\/\/www.cdc.gov\/drugoverdose\/data\/index.html"},{"key":"10.1124\/jpet.120.000124_bib7","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000124_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fbioe.2019.00472","article-title":"High level production of monoclonal antibodies using an optimized plant expression system","volume":"7","author":"Diamos","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1124\/jpet.120.000124_bib9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","article-title":"Efficacy of a therapeutic cocaine vaccine in rodent models","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"key":"10.1124\/jpet.120.000124_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/add.13925","article-title":"Risk factors for severe respiratory depression from prescription opioid overdose","volume":"113","author":"Fox","year":"2018","journal-title":"Addiction"},{"key":"10.1124\/jpet.120.000124_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","article-title":"The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies","volume":"9","author":"Han","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.120.000124_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jim.2016.09.001","article-title":"Refined protocol for generating monoclonal antibodies from single human and murine B cells","volume":"438","author":"Ho","year":"2016","journal-title":"J Immunol Methods"},{"key":"10.1124\/jpet.120.000124_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"key":"10.1124\/jpet.120.000124_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/mab.2014.0098","article-title":"Preparation and characterization of a monoclonal antibody against morphine","volume":"34","author":"Kashanian","year":"2015","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"10.1124\/jpet.120.000124_bib15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.105.004234","article-title":"Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships","volume":"33","author":"Keyler","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000124_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.120.000124_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.116.233510","article-title":"Pharmacological effects of a monoclonal antibody against 6-monoacetylmorphine upon heroin-induced locomotor activity and pharmacokinetics in mice","volume":"358","author":"Kvello","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.118.251504","article-title":"A monoclonal antibody against 6-acetylmorphine protects female mice offspring from adverse behavioral effects induced by prenatal heroin exposure","volume":"368","author":"Kvello","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib19","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41598-018-23777-6","article-title":"Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose","volume":"8","author":"Laudenbach","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.120.000124_bib20","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.1500385","article-title":"The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse","volume":"194","author":"Laudenbach","year":"2015","journal-title":"J Immunol"},{"key":"10.1124\/jpet.120.000124_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fmicb.2019.00672","article-title":"Antigen-specific single B cell sorting and monoclonal antibody cloning in Guinea pigs","volume":"10","author":"Lei","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1124\/jpet.120.000124_bib22","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1039\/C7RA01346A","article-title":"Synthesis and biological evaluation of fentanyl acrylic derivatives","volume":"7","author":"Li","year":"2017","journal-title":"RSC Advances"},{"key":"10.1124\/jpet.120.000124_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1124\/dmd.118.083857","article-title":"A recombinant humanized anticocaine monoclonal antibody alters the urinary clearance of cocaine and its metabolites in rats","volume":"47","author":"Marckel","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000124_bib24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.120.000124_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2018.06.026","article-title":"Prophylactic vaccination protects against the development of oxycodone self-administration","volume":"138","author":"Nguyen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.120.000124_bib26","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1080\/21645515.2016.1212785","article-title":"Biologics to treat substance use disorders: current status and new directions","volume":"12","author":"Pravetoni","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1124\/jpet.120.000124_bib27","doi-asserted-by":"crossref","first-page":"107662","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.120.000124_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000124_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1124\/jpet.120.000014","article-title":"Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity","volume":"374","author":"Raleigh","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.117.247049","article-title":"Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats","volume":"365","author":"Raleigh","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib33","doi-asserted-by":"crossref","first-page":"e115696","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000124_bib34","doi-asserted-by":"crossref","first-page":"e0184876","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000124_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000124_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/21645515.2018.1558697","article-title":"Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders","volume":"15","author":"Robinson","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1124\/jpet.120.000124_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1124\/jpet.120.000124_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1124\/jpet.120.000124_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.120.000124_bib40","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1021\/jacs.9b04872","article-title":"Monoclonal antibodies for combating synthetic opioid intoxication","volume":"141","author":"Smith","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.120.000124_bib41","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1038\/ncomms11804","article-title":"Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment","volume":"7","author":"Spanier","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.120.000124_bib42","doi-asserted-by":"crossref","first-page":"e0152282","DOI":"10.1371\/journal.pone.0152282","article-title":"Generation of recombinant monoclonal antibodies from immunised mice and rabbits via flow cytometry and sorting of antigen-specific IgG+ memory B cells","volume":"11","author":"Starkie","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000124_bib43","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","article-title":"First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"key":"10.1124\/jpet.120.000124_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/acs.jmedchem.7b01427","article-title":"A stable heroin analogue that can serve as a vaccine hapten to induce antibodies that block the effects of heroin and its metabolites in rodents and that cross-react immunologically with related drugs of abuse","volume":"61","author":"Sulima","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000124_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2014.01.010","article-title":"Hapten-specific na\u00efve B cells are biomarkers of vaccine efficacy against drugs of abuse","volume":"405","author":"Taylor","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1124\/jpet.120.000124_bib46","doi-asserted-by":"crossref","first-page":"107730","DOI":"10.1016\/j.neuropharm.2019.107730","article-title":"Vaccine blunts fentanyl potency in male rhesus monkeys","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:00:47Z","timestamp":1739973647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524269664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0022356524269664"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000124","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Antibodies Counteract Opioid-Induced Behavioral and Toxic Effects in Mice and Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}